Issue 7 - Ensuring Accuracy and Integrity in Bioanalytical Methods and Laboratory-Developed Tests
BioBinding Bulletin: Navigating the World of Label-Free Detection

Issue 7 - Ensuring Accuracy and Integrity in Bioanalytical Methods and Laboratory-Developed Tests

Validation of Bioanalytical Methods:

Validation of bioanalytical methods, particularly kinetic-based assays, is a cornerstone of generating accurate and reliable data in scientific research and pharmaceutical development. The validation process is designed to be both comprehensive and transparent, incorporating stringent checks and balances to ensure scientific robustness and ethical reporting. This involves a series of methodical steps, including the calibration of instruments, verification of assay sensitivity, specificity, precision, and accuracy, as well as the establishment of reproducibility and robustness under various conditions. By adhering to rigorous validation protocols, laboratories can contribute to the advancement of medical science and improve patient outcomes.

A critical component for maintaining data accuracy and security is the Octet? 21 CFR Part 11 Software package, which aligns with the FDA's 21 CFR Part 11 regulations. This software suite includes features such as an audit trail, electronic signatures, and robust electronic record-keeping, which are vital for deterring fraud and maintaining data integrity. Sartorius professionals handle the installation to ensure it is implemented correctly.
Approved

Regulation and Standards for Laboratory-Developed Tests:

The FDA underscores the importance of data integrity and has implemented a final rule to regulate laboratory-developed tests (LDTs) as medical devices. This regulation mandates that laboratories adhere to stringent standards of integrity and accuracy in their testing procedures. These measures are critical to ensuring patient safety and the reliability of medical devices, thereby maintaining high standards in the healthcare industry.

Further read:

Fraudulent and Unreliable Laboratory Testing Data in Premarket Submissions: FDA Reminds Medical Device Manufacturers to Scrutinize Third-Party-Generated Data

Medical Devices; Laboratory Developed Tests


More Application Insights

Discover some of our recently released publications.

Video: Octet? Software Tutorials - Part 1 - 20

Compendium: A Compendium for Successful BLI and SPR Assays

Application Note: Fcγ Receptor and Antigen Kinetic Screening for Rapid Biosimilar Downstream Processing Assessment

Application Note: Octet? BLI Kinetic Screening In Biosimilar Development


Octet? Feature

Have you already discovered our Octet? Publication Database? Out of 7,000+ existing Octet? citations, you can access a world of knowledge, boasting over 5,800 peer-reviewed publications across a huge variety of research topics.

Access the Tool Now!

Octet? Publication Database - Building a Solid Foundation of Knowledge

Meet Us at These Upcoming Events

We are excited to meet you in person. Want to learn about the benefits that label-free biomolecular interaction analysis can bring to your lab for fast protein binding kinetics analysis as well as label-free analyte quantification, even in crude samples?

Meet us at:

ILMAC 2024 | September 18 – 19, 2024, Lausanne, Switzerland


It's our pleasure to share with you the latest news about our products and activities. If you have any questions, don't hesitate to ask. We’ll be happy to help.

Get in Touch

要查看或添加评论,请登录

Octet?- Affinity, Binding Kinetics and Concentration的更多文章

社区洞察

其他会员也浏览了